RWE Alliance Supports Califf Nomination, Urges Continued Focus at FDA on Advancing Use of Real-World Evidence to Benefit Patients

Washington, D.C.,

Washington, D.C. (December 13, 2021) – The RWE Alliance supports the nomination of Dr. Robert Califf to serve as Commissioner of the U.S. Food and Drug Administration (FDA).

As a former FDA Commissioner and the founder of the Duke Clinical Research Institute, Dr. Califf is a leader in advancing innovative clinical trial designs and the use of real-world data and evidence to inform regulatory decision making. It is crucial to have an FDA Commissioner that understands the role real-world data and evidence play in improving patients’ lives.

For Media Inquiries: